全球脑血氧仪市场（按产品类型、应用、技术、区域范围）预测至 2025 年

脑体血氧仪的市场规模及预测

2024 年全球脑体血氧仪市场规模为 2.6267 亿美元，预计到 2032 年将达到 4.4457 亿美元，2026 年至 2032 年的复合年增长率为 7.50%。

脑血氧仪是医疗设备，可提供有关脑部氧合和血流的宝贵资讯。

它主要用于在手术、加护治疗和神经系统检查期间监测和管理患者，以发现缺氧和脑缺血等潜在问题。

脑体血氧仪的未来包括非侵入性监测技术的进步、与更广泛的健康监测系统的整合以及在各种临床环境中的扩展使用，所有这些都受到持续的技术创新和对准确大脑健康监测日益增长的需求的推动。

全球脑体血氧仪市场动态

影响全球脑体血氧仪市场的关键市场动态是：

关键市场驱动因素

神经系统疾病盛行率不断上升：中风和脑损伤等神经系统疾病盛行率不断上升，推动了对脑血氧仪的需求。 2024年6月，Medtronic扩大了其脑监测解决方案的产品范围，以满足日益增长的医疗保健需求。

监测设备的技术发展：血氧测定技术的进步，例如改进的感测器和即时数据分析，将提高脑体血氧仪的准确性和功能性。例如，2024年7月，Nonin Medical推出了一款新型先进脑血氧仪，其讯号处理能力已提升。

更加重视病人安全和监测。在手术和重症加护期间，病人安全和持续监测受到更多重视。 2024年4月，美国食品药物管理局（FDA）核准了一种新型脑血氧仪，标誌着监管机构对先进监测技术的支持日益增强。

医疗设施的扩张和投资：医疗基础设施的扩张和对先进诊断工具的投资正在推动市场成长。飞利浦医疗保健于2024年3月宣布了一项重大投资，以扩展其脑血氧仪产品线，以满足医院和外科中心日益增长的需求。

主要挑战

先进设备高成本：先进的脑血氧仪价格高昂，可能成为其普及的重大障碍，尤其是在资源匮乏的医疗环境中。此类设备的高昂成本往往会限制最尖端科技的普及。

准确度和校准差异：由于校准和感测器技术的差异，脑血氧仪的准确度差异可能是一个问题。在多种设备和不同患者条件下保持一致可靠的测量结果仍然是首要任务。

与现有系统整合的复杂性：将脑体血氧仪整合到现有的医疗监测系统中可能比较困难，并且需要额外的基础设施改造。对于医疗机构而言，这个整合过程既困难又耗时。

认识和培训有限：医疗保健专业人员通常缺乏如何正确使用脑血氧仪的认识或培训，这可能导致使用效率低下和低估该设备在患者照护中的潜在益处。

主要趋势

先进监测系统的整合：将脑血氧仪与其他先进监测系统（例如麻醉和重症加护设备）相结合的趋势日益增长。这种整合增强了全面的病患监测和即时数据分析，从而改善临床疗效。

穿戴式和行动装置的发展：穿戴式和可携式脑血氧仪可以在传统医院环境之外进行持续、方便的监测，并且越来越受欢迎。

非侵入性技术的进步：技术进步旨在改进非侵入性测量技术，从而获得更准确、更可靠的脑血氧饱和度数据。最近的进展包括先进的感测器技术和改进的讯号处理演算法。

在各种临床环境中的应用日益广泛：脑体血氧仪在神经外科以外的临床环境中的应用日益广泛，例如循环系统和产科。这些设备在各个医疗领域的应用表明，它们在监测各种患者状况下的脑氧水平方面的效用日益增强。

目录

第一章 引言

• 市场定义
• 市场区隔
• 调查方法

第二章执行摘要

• 主要发现
• 市场概览
• 市集亮点

第三章市场概述

• 市场规模和成长潜力
• 市场趋势
• 市场驱动因素
• 市场限制
• 市场机会
• 波特五力分析

第四章脑体血氧仪市场（依产品类型）

• 非侵入性脑体血氧仪
• 侵入式脑体血氧仪

第五章脑血氧仪市场（依应用）

• 神经重症重症加护
• 麻醉学
• 新生儿护理
• 循环系统
• 运动医学

第六章脑血氧仪市场（依技术）

• 近红外线光谱（NIRS）
• 光声光谱（PAS）
• 漫波相关光谱（DCS）

第七章区域分析

• 北美洲
• 美国
• 加拿大
• 墨西哥
• 欧洲
• 英国
• 德国
• 法国
• 义大利
• 亚太地区
• 中国
• 日本
• 印度
• 澳洲
• 拉丁美洲
• 巴西
• 阿根廷
• 智利
• 中东和非洲
• 南非
• 沙乌地阿拉伯
• 阿拉伯聯合大公国

第八章市场动态

• 市场驱动因素
• 市场限制
• 市场机会
• COVID-19 市场影响

第九章 竞争态势

• 主要企业
• 市场占有率分析

第十章 公司简介

• Masimo
• Medtronic
• Edwards Lifesciences
• ISS Inc.
• Nonin Medical, Inc.
• Koninklijke Philips NV
• Mespere LifeSciences
• GE Healthcare

第十一章 市场展望与机会

• 新兴技术
• 未来市场趋势
• 投资机会

第十二章 附录

• 简称列表
• 来源和参考文献

Cerebral Somatic Oximeters Market Size And Forecast

Global Cerebral Somatic Oximeters Market size was valued at USD 262.67 Million in 2024 and is projected to reach USD 444.57 Million by 2032, growing at a CAGR of 7.50% from 2026 to 2032.

Cerebral somatic oximeters are medical devices that measure oxygen levels in brain tissues, providing valuable information about cerebral oxygenation and blood flow.

They are primarily used to monitor and manage patients during surgeries, intensive care, and neurological examinations in order to detect potential problems such as hypoxia or brain ischemia.

The future of cerebral somatic oximeters includes advancements in non-invasive monitoring technologies, integration with broader health monitoring systems, and expanded use in a variety of clinical settings, all driven by ongoing innovation and the growing demand for precise cerebral health monitoring.

Global Cerebral Somatic Oximeters Market Dynamics

The key market dynamics that are shaping the global cerebral somatic oximeters market include:

Key Market Drivers:

Increasing Prevalence of Neurological Disorders: The growing prevalence of neurological disorders, such as stroke and brain injuries, is driving up demand for cerebral somatic oximeters. Medtronic expanded its range of cerebral monitoring solutions in June 2024 to meet the growing healthcare demand.

Technological Developments in Monitoring Devices: Oximetry technology advancements, such as improved sensors and real-time data analysis, improve the accuracy and functionality of cerebral somatic oximeters. For example, in July 2024, Nonin Medical unveiled a new advanced cerebral oximeter with improved signal processing capabilities.

Growing Emphasis on Patient Safety and Monitoring: There is a greater emphasis on patient safety and continuous monitoring during surgeries and critical care. In April 2024, the US Food and Drug Administration (FDA) approved a new cerebral oximeter device, demonstrating increased regulatory support for advanced monitoring technologies.

Expansion of Healthcare Facilities and Investments: The expansion of healthcare infrastructure, as well as investments in advanced diagnostic tools, are driving market growth. Philips Healthcare announced a significant investment in March 2024 to expand its cerebral oximetry product line in response to increasing demand in hospitals and surgical centers.

Key Challenges:

High Cost of Advanced Devices: The high cost of advanced cerebral somatic oximeters can be a significant barrier to adoption, particularly in low-resource healthcare settings. Access to cutting-edge technologies is frequently limited due to the high cost of such equipment.

Variability in Accuracy and Calibration: Variability in cerebral oximeter accuracy can be problematic due to differences in calibration and sensor technology. Maintaining consistent and reliable readings across multiple devices and patient conditions remains a top priority.

Complexity of Integration with Existing Systems: Integrating cerebral somatic oximeters with current medical monitoring systems can be difficult and may necessitate additional infrastructure changes. This integration process can be difficult and time-consuming for healthcare facilities.

Limited Awareness and Training: Healthcare professionals frequently lack awareness and training on how to use cerebral somatic oximeters properly. This can result in inefficient use and underestimation of the device's potential benefits in patient care.

Key Trends:

Integration of Advanced Monitoring Systems: There is an increasing trend of combining cerebral somatic oximeters with other advanced monitoring systems, such as anesthesia and critical care equipment. This integration enhances comprehensive patient monitoring and real-time data analysis, resulting in better clinical outcomes.

Development of Wearable and Portable Devices: Wearable and portable cerebral oximeters are becoming increasingly popular, allowing for continuous and convenient monitoring outside of traditional hospital settings.

Advancements in Non-invasive Technologies: Technological advancements are aimed at improving non-invasive measurement techniques, resulting in more accurate and reliable cerebral oxygenation data. Recent advancements include advanced sensor technologies and improved signal processing algorithms.

Growing Use in Various Clinical Settings: Cerebral somatic oximeters are increasingly used in clinical settings other than neurosurgery, such as cardiology and obstetrics. The use of these devices in various medical fields demonstrates their growing utility in monitoring cerebral oxygen levels in a variety of patient conditions.

Global Cerebral Somatic Oximeters Market Regional Analysis

Here is a more detailed regional analysis of the global cerebral somatic oximeters market:

North America:

North America is emerging as the dominant force in the cerebral somatic oximeters market, owing to advanced healthcare infrastructure, high adoption rates of cutting-edge medical technologies, and significant R&D investments. The United States, in particular, dominates this market due to its large number of well-equipped hospitals, strict patient safety regulations, and high prevalence of cardiovascular and neurological disorders.

The region's dominance is reinforced by the presence of major market players such as Medtronic, Edwards Lifesciences, and Nonin Medical, which are constantly innovating and improving their cerebral oximetry technology. Furthermore, the growing emphasis on reducing perioperative complications and improving patient outcomes in surgical and critical care settings has accelerated the adoption of these devices in North American healthcare facilities.

In February 2024, Medtronic unveiled its next-generation cerebral somatic oximeter which includes artificial intelligence to provide more accurate tissue oxygenation monitoring during complex surgeries. This launch is expected to strengthen Medtronic's market position and accelerate adoption rates in North American hospitals. In April 2024, the United States Food and Drug Administration (FDA) issued new guidelines for the use of cerebral oximetry in pediatric cardiac surgeries, emphasizing the importance of continuous cerebral monitoring in high-risk procedures. This regulatory update is expected to increase demand for cerebral somatic oximeters in pediatric care units across the United States, thereby expanding the market in North America.

Asia Pacific:

The Asia Pacific region is projected to witness fastest growth in the cerebral somatic oximeters, owing to increased awareness of patient monitoring during surgeries, rising healthcare costs, and growing adoption of advanced medical technologies. Countries such as China, Japan, India, and South Korea are at the forefront of this expansion, with large populations and rapidly developing healthcare infrastructures driving significant demand for these devices. The region's emphasis on improving patient outcomes, particularly in critical care and surgical settings, has resulted in an increase in the use of cerebral oximeter technology. Furthermore, the rising prevalence of cardiovascular and neurological disorders among Asia's aging populations has increasing demand for these monitoring devices.

In March 2024, Masimo Corporation, a global leader in noninvasive monitoring technologies, announced that it would expand its manufacturing facilities in Malaysia to meet Asia Pacific's growing demand for cerebral oximeters. This move is expected to significantly boost the availability of these devices in the region. In January 2024, the Chinese National Health Commission announced a new five-year plan to improve perioperative patient safety, which includes significant investments in advanced monitoring technologies such as cerebral somatic oximeters. This initiative is expected to increase the adoption of these devices in Chinese hospitals, accelerating market growth in the Asia Pacific region.

Global Cerebral Somatic Oximeters Market: Segmentation Analysis

The Global Cerebral Somatic Oximeters Market is segmented on the basis of By Product Type, By Application, By Technology and Geography.

Global Cerebral Somatic Oximeters Market, By Product Type

• Non-invasive Cerebral Somatic Oximeters
• Invasive Cerebral Somatic Oximeters

Based on Product Type, the Global Cerebral Somatic Oximeters Market is segmented into Non-invasive Cerebral Somatic Oximeters and Invasive Cerebral Somatic Oximeters. Non-invasive cerebral somatic oximeters are popular due to their widespread use and preference for monitoring without the need for surgical procedures, resulting in ease of use and patient comfort. The invasive cerebral somatic oximeters segment is the fastest growing, driven by rising demand for precise and direct measurements in complex and high-risk medical procedures where accuracy is critical.

Global Cerebral Somatic Oximeters Market, By Application

• Neurocritical Care
• Anesthesiology
• Neonatal Care
• Cardiology
• Sports Medicine

Based on Application, the Global Cerebral Somatic Oximeters Market is segmented into Neurocritical Care, Anesthesiology, Neonatal Care, Cardiology, and Sports Medicine. The neurocritical care segment is dominant because it plays an important role in monitoring cerebral oxygenation in patients with severe neurological conditions and during complex surgeries. The neonatal care segment is expanding at the fastest rate, owing to increased awareness of the importance of monitoring cerebral oxygen levels in newborns and advances in neonatal care technology.

Global Cerebral Somatic Oximeters Market, By Technology

• Near-infrared spectroscopy (NIRS)
• Photoacoustic spectroscopy (PAS)
• Diffuse correlation spectroscopy (DCS)

Based on Technology, the Global Cerebral Somatic Oximeters Market is segmented into Near-infrared spectroscopy (NIRS), Photoacoustic spectroscopy (PAS), Diffuse correlation spectroscopy (DCS). Near-infrared spectroscopy (NIRS) is the dominant technology due to its long history of use in non-invasive monitoring of cerebral oxygenation and widespread adoption in clinical settings. Diffuse correlation spectroscopy (DCS) is the fastest-growing segment, thanks to its advanced capabilities for real-time measurements of cerebral blood flow and oxygenation, which has sparked increased interest and investment in this emerging technology.

Global Cerebral Somatic Oximeters Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the World

Based on the Geography, the Global Cerebral Somatic Oximeters Market are classified into North America, Europe, Asia Pacific, and Rest of the World. North America is the dominant region due to its advanced healthcare infrastructure, widespread adoption of medical technologies, and the presence of major medical device manufacturers. Asia Pacific is the fastest-growing region, owing to increased investments in healthcare infrastructure, rising prevalence of neurological disorders, and rising demand for advanced monitoring solutions in emerging economies such as China and India.

Key Players

The "Global Cerebral Somatic Oximeters Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Masimo, Medtronic, Edwards Lifesciences, ISS, Inc., Nonin Medical, Inc., Mespere LifeSciences, GE Healthcare.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

• Global Cerebral Somatic Oximeters Market: Recent Developments
• In April 2024, Philips Healthcare introduced a new line of cerebral somatic oximeters that incorporate cutting-edge technology for better patient monitoring and integration with existing healthcare systems.
• In May 2024, Nihon Kohden launched a portable cerebral oximeter with the goal of providing continuous monitoring in a variety of clinical settings, including emergency and neonatal care, while also improving mobility and ease of use.
• In March 2024, Nonin Medical introduced a new cerebral oximeter with upgraded sensor technology, promising improved accuracy and reliability in a variety of patient conditions, including critical and routine monitoring.

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Cerebral Somatic Oximeters Market, By Product Type

• Non-invasive Cerebral Somatic Oximeters
• Invasive Cerebral Somatic Oximeters

5 Crebral Somatic Oximeters Market, By Application

• Neurocritical Care
• Anesthesiology
• Neonatal Care
• Cardiology
• Sports Medicine

6 Cerebral Somatic Oximeters Market, By Technology

• Near-infrared spectroscopy (NIRS)
• Photoacoustic spectroscopy (PAS)
• Diffuse correlation spectroscopy (DCS)

7. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

8. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

9. Competitive Landscape

• Key Players
• Market Share Analysis

10. Company Profiles

• Masimo
• Medtronic
• Edwards Lifesciences
• ISS Inc.
• Nonin Medical, Inc.
• Koninklijke Philips N.V.
• Mespere LifeSciences
• GE Healthcare

11. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

12. Appendix

• List of Abbreviations
• Sources and References